PMID- 29607201 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210315 IS - 2072-1439 (Print) IS - 2077-6624 (Electronic) IS - 2072-1439 (Linking) VI - 10 IP - 2 DP - 2018 Feb TI - Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients. PG - E125-E129 LID - 10.21037/jtd.2018.01.127 [doi] AB - Thymic carcinoid is a rare but very aggressive neuroendocrine tumour derived from the neuroendocrine system. Here we report a male patient with thymic atypical carcinoid. Though thymic carcinoid is relatively common, the gene sequencing profile was performed and the gene sequencing result indicated germline multiple endocrine neoplasia type 1 (MEN1) mutation and two somatic mutations on MEN1 gene and no copy number variation or fusion events were detected. It is well-known that the mutation of MEN1 is the typical manifestation of MEN1 syndrome, which is an autosome dominant disease that includes varying combinations of more than 20 endocrine and non-endocrine tumors. In the English literature, 7 cases of solitary thymic carcinoid harboring somatic variants in MEN1 are reported in the absence of other organs involvement as MEN1 syndrome presents. We summarized the clinical features and prognosis of this rare thymic tumor. FAU - Li, Xiongfei AU - Li X AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Li, Mingbiao AU - Li M AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Shi, Tao AU - Shi T AD - Department of Pathology, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Liu, Renwang AU - Liu R AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Ren, Dian AU - Ren D AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Yang, Fan AU - Yang F AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Wei, Sen AU - Wei S AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Chen, Gang AU - Chen G AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Chen, Jun AU - Chen J AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. AD - Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Xu, Song AU - Xu S AD - Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. AD - Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. LA - eng PT - Case Reports PL - China TA - J Thorac Dis JT - Journal of thoracic disease JID - 101533916 EIN - J Thorac Dis. 2021 Feb;13(2):1300-1301. PMID: 33717601 PMC - PMC5864637 OTO - NOTNLM OT - Multiple endocrine neoplasia type 1 (MEN1) OT - next generation sequencing (NGS) OT - prognosis OT - thymic carcinoid COIS- Conflicts of Interests: The authors have no conflicts of interest to declare. EDAT- 2018/04/03 06:00 MHDA- 2018/04/03 06:01 PMCR- 2018/02/01 CRDT- 2018/04/03 06:00 PHST- 2018/04/03 06:00 [entrez] PHST- 2018/04/03 06:00 [pubmed] PHST- 2018/04/03 06:01 [medline] PHST- 2018/02/01 00:00 [pmc-release] AID - jtd-10-02-E125 [pii] AID - 10.21037/jtd.2018.01.127 [doi] PST - ppublish SO - J Thorac Dis. 2018 Feb;10(2):E125-E129. doi: 10.21037/jtd.2018.01.127.